Foreign-Trade Zone (FTZ) 27-Boston, Massachusetts; Authorization of Production Activity, Wyeth Pharmaceuticals, LLC (Shingles and Flu Vaccines), Andover, Massachusetts, 1558-1559 [2023-00355]

Download as PDF lotter on DSK11XQN23PROD with NOTICES1 1558 Federal Register / Vol. 88, No. 7 / Wednesday, January 11, 2023 / Notices As noted above, the 56 Advisory Committees advise the Commission on civil rights issues that the Committees choose to evaluate. The Commission may also ask Advisory Committees to take up a civil rights topic in support of a Commission investigation. After a Committee’s report is submitted, the Commission may invite the Advisory Committee Chair to discuss the report, including the findings and recommendations, at regularly scheduled Commission business meetings. The Commission may notify the U.S. Congressional delegation for the particular locale that the advisory committee within their jurisdiction has published a report. In addition, the Commission may distribute Committee reports to the federal, state, and local bodies that are identified in the Committee report. Lastly, individual Commissioners often attend the Advisory Committee meetings, which are open to the general public. The USCCR identifies candidates for advisory committee membership through a variety of methods, including, but not limited to, public requests for nominations; recommendations from existing advisory committee members; consultations with knowledgeable persons outside the USSCR (academia, non-profits, other state or federal government agencies, academia, etc.); and Commissioners’ and USCCR staff’s professional knowledge of those experienced in civil rights. Following the identification process, the USCCR develops a list of proposed members with the relevant points of view needed to ensure membership balance. The USCCR Commissioners then vote to appoint individuals to serve four-year terms as Advisory Committee Members. Advisory Committee Members are generally classified as Representatives. Representatives provide the viewpoints of entities or recognizable groups and are expected to potentially represent a particular and known bias or perspective. The collection of information is necessary to support the USCCR Advisory Committees by placing qualified individuals on them as members. Pursuant to the FACA, an agency must ensure that a committee is balanced with respect to the viewpoints represented and the functions to be performed by that committee. Consistent with this, in order to select individuals for potential membership on an advisory committee, the USCCR must determine that potential members are qualified to serve on an advisory committee and that the viewpoints are properly balanced on the committee. VerDate Sep<11>2014 17:17 Jan 10, 2023 Jkt 259001 USCCR staff would use the information collected to determine the members come from the rich and diverse backgrounds of all of the United States and its Territories that USCCR wishes to have represented on its Advisory Committees, to determine the civil rights experience and expertise of potential advisory committee members, and to ensure that the membership on a committee is balanced. The USCCR seeks to collect the following information: Information that supports an individual’s state or territory residency requirements, civil rights experience and expertise to serve on an advisory committee, including a letter discussing their qualifications, resume or curriculum vitae, and/or other similar biographical information documents such as name and address and social media handles. Additionally, the USCCR seeks to collect information that ensures membership balance (e.g., represented viewpoint category), and that potential members broadly represent the demographics and/or viewpoints of the United States and its Territories’ varied and diverse backgrounds including, but not limited to, education, occupation, political affiliation and/or ideology, race/ ethnicity, national origin, gender, sexual orientation, disability status, age, religion, and veteran status. With respect to the collection of information, the USCCR invites comments on: • Whether the proposed collection of information is necessary for the proper performance of the functions of the Commission, including whether the information will have a practical use; • The accuracy of the Commission’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; • Ways to enhance the quality, usefulness, and clarity of the information to be collected; and • Ways to minimize the burden of collection of information on those who are to respond, including through the use of appropriate automated electronic, mechanical, or other technological collection techniques or other forms of information technology; e.g., permitting electronic submission of responses. You should submit only information that you wish to make available publicly. If you wish the Commission to consider information that you believe is exempt from disclosure under the Freedom of Information Act, a petition for confidential treatment of the exempt information may be submitted according PO 00000 Frm 00003 Fmt 4703 Sfmt 4703 to the procedures established in § 704.1 of the Commission’s regulations.2 The Commission reserves the right, but shall have no obligation, to review, pre-screen, filter, redact, refuse or remove any or all of your submission from https://www.USCCR.gov or other USCCR website to which it posts comments that it may deem to be inappropriate for publication, such as obscene language. All submissions that have been redacted or removed that contain comments on the merits of the Information Collection Request will be retained in the public comment file and will be considered as required under the Administrative Procedure Act and other applicable laws, and may be accessible under the Freedom of Information Act. Burden Statement: The respondent burden for this collection is estimated to be as follows for each currently vacant Advisory Committee: Estimated Number of Respondents: 22. Estimated Average Burden Hours per Respondent: 1.5 hours. Estimated Total Annual Burden Hours: 33 hours. Frequency of Collection: As needed. There are no capital costs or operating and maintenance costs associated with this collection. (Authority: 44 U.S.C. 3501 et seq.) Dated: January 6, 2022. David Ganz, General Counsel, USCCR. [FR Doc. 2023–00371 Filed 1–10–23; 8:45 am] BILLING CODE 6335–01–P DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [B–43–2022] Foreign-Trade Zone (FTZ) 27—Boston, Massachusetts; Authorization of Production Activity, Wyeth Pharmaceuticals, LLC (Shingles and Flu Vaccines), Andover, Massachusetts On September 8, 2022, Wyeth Pharmaceuticals, LLC (Wyeth) submitted a notification of proposed production activity to the FTZ Board for its facility within Subzone 27R, in Andover, Massachusetts. The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the Federal Register inviting public comment (87 FR 56928, September 16, 2022). On January 6, 2023, the applicant was notified of the 2 45 E:\FR\FM\11JAN1.SGM CFR 704.1. 11JAN1 Federal Register / Vol. 88, No. 7 / Wednesday, January 11, 2023 / Notices FTZ Board’s decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Board’s regulations, including Section 400.14. Dated: January 6, 2023. Elizabeth Whiteman, Acting Executive Secretary. [FR Doc. 2023–00355 Filed 1–10–23; 8:45 am] BILLING CODE 3510–DS–P DEPARTMENT OF COMMERCE Bureau of Industry and Security Emerging Technology Technical Advisory Committee; Notice of Partially Closed Meeting The Emerging Technology Technical Advisory Committee (ETTAC) will meet on January 27, 2023, at 9 a.m., (Eastern Standard Time) in the Herbert C. Hoover Building, Room 3884, 1401 Constitution Avenue NW, Washington, DC (enter through Main Entrance on 14th Street between Constitution and Pennsylvania Avenues). The Committee advises the Office of the Assistant Secretary for Export Administration on the identification of emerging and foundational technologies with potential dual-use applications as early as possible in their developmental stages both within the United States and abroad. Agenda Closed Session: 9:30 a.m.–2:30 p.m. 1. Discussion of matters determined to be exempt from the provisions relating to public meetings found in 5 U.S.C. app. §§ 10(a)(1) and 10(a)(3). lotter on DSK11XQN23PROD with NOTICES1 Open Session: 2:40 p.m.–4:00 p.m. 2. Welcome and Introductions. 3. Introducing Speaker from Pew Research Center. 4. Presentation: Artificial Intelligence and Society: What Do People Say? Questions and Answers. 5. Public comments. 6. Announcements. The open session will be accessible via teleconference. To join the conference, submit inquiries to Ms. Yvette Springer at Yvette.Springer@ bis.doc.gov no later than January 20, 2023. A limited number of seats will be available for the public session. Reservations are not accepted. To the extent that time permits, members of the public may present oral statements to VerDate Sep<11>2014 17:17 Jan 10, 2023 Jkt 259001 the Committee. The public may submit written statements at any time before or after the meeting. However, to facilitate the distribution of public presentation materials to the Committee members, the Committee suggests that presenters forward the public presentation materials prior to the meeting to Ms. Springer via email. The Assistant Secretary for Administration, with the concurrence of the delegate of the General Counsel, formally determined on October 20, 2022, pursuant to Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. app. § 10(d)), that the portion of the meeting dealing with predecisional changes to the Commerce Control List and the U.S. export control policies shall be exempt from the provisions relating to public meetings found in 5 U.S.C. app. §§ 10(a)(1) and 10(a)(3). The remaining portions of the meeting will be open to the public. For more information, contact Ms. Springer via email. Yvette Springer, Committee Liaison Officer. [FR Doc. 2023–00311 Filed 1–10–23; 8:45 am] BILLING CODE 3510–JT–P DEPARTMENT OF COMMERCE International Trade Administration [A–570–898] Chlorinated Isocyanurates From the People’s Republic of China: Final Results of Antidumping Duty Administrative Review; 2020–2021 Enforcement and Compliance, International Trade Administration, Department of Commerce. SUMMARY: The U.S. Department of Commerce (Commerce) determines that Heze Huayi Chemical Co., Ltd. (Heze Huayi) and Juancheng Kangtai Chemical Co., Ltd. (Kangtai) sold chlorinated isocyanurates (chlorinated isos) from the People’s Republic of China (China) at less than normal value during the period of review (POR) June 1, 2020, through May 31, 2021. DATES: Applicable January 11, 2023. FOR FURTHER INFORMATION CONTACT: Sean Carey, AD/CVD Operations, Office VII, Enforcement and Compliance, International Trade Administration, U.S. Department of Commerce, 1401 Constitution Avenue NW, Washington, DC 20230; telephone: (202) 482–3964. SUPPLEMENTARY INFORMATION: AGENCY: Background The petitioners in this proceeding are Bio-lab, Inc., Clearon Corp., and PO 00000 Frm 00004 Fmt 4703 Sfmt 4703 1559 Occidental Chemical Corp. (collectively, the petitioners). The mandatory respondents in this administrative review are Heze Huayi and Kangtai. On July 12, 2022, Commerce published its Preliminary Results.1 For events subsequent to the Preliminary Results, see the Issues and Decision Memorandum.2 On October 12, 2022,3 in accordance with section 751(a)(3)(A) of the Tariff Act of 1930, as amended (the Act), Commerce extended the deadline for issuing these final results until January 3, 2023. Scope of the Order The products covered by the order are chlorinated isos, which are derivatives of cyanuric acid, described as chlorinated s-triazine triones. For a full description of the scope of the order, see the Issues and Decision Memorandum.4 Analysis of Comments Received All issues raised by interested parties in briefs are addressed in the Issues and Decision Memorandum. A list of the issues addressed in the Issues and Decision Memorandum is provided in the appendix to this notice. The Issues and Decision Memorandum is a public document and is on file electronically via Enforcement and Compliance’s Antidumping and Countervailing Duty Centralized Electronic Service System (ACCESS). ACCESS is available to registered users at https:// access.trade.gov. In addition, a complete version of the Issues and Decision Memorandum can be accessed directly at https://access.trade.gov/public/ FRNoticesListLayout.aspx. Separate Rate Respondents In the Preliminary Results, we found that Heze Huayi and Kangtai demonstrated their eligibility for a separate rate.5 We received no arguments since the issuance of the Preliminary Results that provide a basis for reconsideration of these determinations. Therefore, for the final results, we continue to find that Heze 1 See Chlorinated Isocyanurates from the People’s Republic of China: Preliminary Results of Antidumping Administrative Review; 2020–2021, 87 FR 41286 (July 12, 2022) (Preliminary Results), and accompanying Preliminary Decision Memorandum (PDM). 2 See Memorandum, ‘‘Issues and Decision Memorandum for the Final Results of the Antidumping Duty Administrative Review: Chlorinated Isocyanurates from the People’s Republic China; 2020–2021,’’ dated concurrently with, and hereby adopted by, this notice (Issues and Decision Memorandum). 3 See Memorandum, ‘‘Extension of Deadline for Final Results of Antidumping Duty Administrative Review,’’ dated October 12, 2022. 4 See Preliminary Results PDM at 2–3. 5 See Preliminary Results, 87 FR at 41286–87. E:\FR\FM\11JAN1.SGM 11JAN1

Agencies

[Federal Register Volume 88, Number 7 (Wednesday, January 11, 2023)]
[Notices]
[Pages 1558-1559]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-00355]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-43-2022]


Foreign-Trade Zone (FTZ) 27--Boston, Massachusetts; Authorization 
of Production Activity, Wyeth Pharmaceuticals, LLC (Shingles and Flu 
Vaccines), Andover, Massachusetts

    On September 8, 2022, Wyeth Pharmaceuticals, LLC (Wyeth) submitted 
a notification of proposed production activity to the FTZ Board for its 
facility within Subzone 27R, in Andover, Massachusetts.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (87 FR 56928, September 16, 2022). On 
January 6, 2023, the applicant was notified of the

[[Page 1559]]

FTZ Board's decision that no further review of the activity is 
warranted at this time. The production activity described in the 
notification was authorized, subject to the FTZ Act and the FTZ Board's 
regulations, including Section 400.14.

    Dated: January 6, 2023.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2023-00355 Filed 1-10-23; 8:45 am]
BILLING CODE 3510-DS-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.